Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 0.03.

  • Centessa Pharmaceuticals' Asset Utilization Ratio rose 72594.3% to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year increase of 72594.3%. This contributed to the annual value of 0.02 for FY2023, which is N/A changed from last year.
  • Latest data reveals that Centessa Pharmaceuticals reported Asset Utilization Ratio of 0.03 as of Q3 2025, which was up 72594.3% from 0.03 recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.03 for Q3 2025, and its period low was 0.03 during Q4 2023.
  • Moreover, its 4-year median value for Asset Utilization Ratio was 0.02 (2022), whereas its average is 0.01.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 7044.04% in 2023, then surged by 72594.3% in 2025.
  • Centessa Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.02 in 2022, then plummeted by 70.44% to 0.03 in 2023, then skyrocketed by 81.03% to 0.01 in 2024, then soared by 725.94% to 0.03 in 2025.
  • Its last three reported values are 0.03 in Q3 2025, 0.03 for Q2 2025, and 0.03 during Q1 2025.